With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.578743-87-0,[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]copper chloride,as a common compound, the synthetic route is as follows.,578743-87-0
Carbazole (83.6mg, 0.5mmol) and NaH (12 mg, 0.5 mmol) was mixed with THF and 15 ml, atroom temperature under a nitrogen atmosphere until bubbling ceased (15 min) and stirred.Chloro [1,3-bis (2,6-diisopropylphenyl) imidazol-2-ylidene] was added copper (I) ((IPr) CuCl)(243.8mg, 0.5mmol), the reaction mixture was stirred for one hour did. Then, the mixture wasfiltered through a plug of Celite (registered trademark) under an inert atmosphere, and thesolvent was removed by rotary evaporation. The product was obtained as a white solid (170mg,55%).
The synthetic route of 578743-87-0 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Universal Display Corporation; Mark, E. Thomson; Peter, I. Jurobitchi; Valentina, Krirowa; (66 pag.)JP2015/91800; (2015); A;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”